Methods for rapid antimicrobial susceptibility testing
The present invention relates, in part, to methods and kits for rapidly determining antimicrobial susceptibility of microorganisms.
1. A method for determining antimicrobial susceptibility of microorganisms comprising:
(a) incubating a liquid suspension of microorganisms in the presence of an antimicrobial under conditions that promote growth of the microorganisms,
(b) adding a signaling agent comprising a lanthanide signal amplifier and one or more chemical moieties that binds-non-specifically to a surface of the microorganisms;
(c) separating the microorganisms bound by the signaling agent from unbound signaling agent; and
(d) measuring an optical signal from the signaling agent bound to the surface of the microorganisms as compared to one or more controls, thereby measuring a relative surface area of the microorganisms.
2. The method of claim 1 , wherein the one or more chemical moieties of the signaling agent is selected from the group consisting of:
an antibody, lectin, natural peptide, synthetic peptides, bacteriophage, synthetic and/or natural ligands, synthetic and/or natural polymers, synthetic and/or natural glycopolymers, carbohydrate-binding proteins and/or polymers, glycoprotein-binding proteins and/or polymers, charged small molecules, other proteins, bacteriophages, and/or aptamers; and
an amplifier group 104 that comprises a lanthanide coordination complex.
3. The method of claim 2 , wherein the ligand and/or peptide is selected from the group consisting of bis(zinc-dipicolylamine), TAT peptide, serine proteases, cathelicidins, cationic dextrins, cationic cyclodextrins, salicylic acid, lysine, and combinations thereof.
4. The method of claim 1 , wherein the antimicrobial susceptibility of the microorganisms is determined in less than 5 hours.
5. The method of claim 1 , wherein adding the signaling agent occurs after the incubating step.
6. The method of claim 1 , wherein the signaling agent forms a non-covalent interaction with the surface of a microorganism, wherein the non-covalent interaction comprises ionic interactions, van der Waals interactions, hydrophobic interactions, n-n interactions, or hydrogen bonding, or any combination thereof.
7. The method of claim 1 , wherein multiple antimicrobials are tested in parallel.
8. The method of claim 1 , wherein the determining signal levels comprises measuring the signal levels associated with intact microorganisms.
9. The method of claim 1 , wherein the method further comprises a step of determining whether a microorganism is resistant, intermediately resistant or susceptible to one or more antimicrobials and/or determining one or more antimicrobial minimum inhibitory concentrations (MIC) based upon the signal levels associated with intact microorganisms.
10. The method of claim 1 wherein the microorganisms are bacteria, fungi, protozoa, or archaea.
11. The method of claim 1 , wherein the microorganisms are obtained from a biological sample from a subject having an infection of the microorganisms and/or are obtained from a culture derived from the biological sample.
12. The method of claim 11 , wherein the biological sample is selected from the group consisting of blood or blood components, bronchoalveolar lavage, cerebrospinal fluid, nasal swabs, sputum, stool, throat swabs, vaginal swabs, urine, aft6- or wound swabs, or a combination thereof.
13. The method of claim 1 , wherein the one or more controls comprise a positive control measured from microorganisms under otherwise identical conditions but without antimicrobials or with one or more antimicrobials for which the microorganisms are not susceptible.
14. The method of claim 1 , wherein the one or more controls comprise a control measured from microorganisms under otherwise identical conditions but without nutrients.
15. The method of claim 1 , wherein the one or more controls comprise a control measured from microorganisms under otherwise identical conditions with one or more toxins known to inhibit growth of the microorganisms.
16. The method of claim 1 , wherein the separating the microorganisms is performed by centrifugation, magnetic separation, filtration, electrophoresis, dielectrophoresis, precipitation, agglutination, or a combination thereof.
17. A method for determining antimicrobial susceptibility of microorganisms comprising:
(a) incubating, under conditions that promote growth of the microorganisms, a liquid suspension of microorganisms in a cartridge comprising a plurality of chambers defining dilution series for one or more antimicrobials;
(b) adding a signaling agent comprising a lanthanide signal amplifier and one or more chemical moieties to the plurality of chambers, wherein the signaling agent binds non-specifically to a surface of the microorganisms; and
(c) measuring an optical signal from the signaling agent bound to the surf ace of the microorganisms in the plurality of chambers as compared to one or more controls, thereby determining the relative surface area of microorganisms.
18. The method of claim 17 , wherein the antimicrobial susceptibility of the microorganisms is determined in less than 5 hours.
19. The method of claim 17 , further comprising removing unbound signaling agent.
20. The method of claim 17 , wherein the one or more controls comprise a positive control measured from microorganisms under otherwise identical conditions but without antimicrobials or with one or more antimicrobials for which the microorganisms are not susceptible.
21. The method of claim 17 , wherein the signaling agent forms covalent bond with the surface of the microorganism in the presence of one or more agents that promote coupling, selected from the group consisting of glutaraldehyde, formaldehyde, paraformaldehyde, 1:ethyl-3-(3 dimethylaminopropyl)carbodiimide, N-(3-dimethylaminopropyl)-N′-ethylcarbonate, N,N′-dicyclohexylcarbodiimide, N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide-methyl-p-toluenesulfonate, diisopropylcarbodiimide, 1[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate, Woodward's Reagent, N,N′-carbony 1 diimidazole, acrylates, amides, imides, anhydrides, chlorotriazines, epoxides, isocyanates, isothiocyanates, organic acids, monomers, polymers, silanes, silcates, NHS, sulfa-NHS, and a combination thereof.
22. The method of claim 17 , wherein the microorganisms are obtained from a biological sample from a subject having an infection of the microorganisms and/or obtained from a culture derived from the biological sample; and wherein the biological sample is selected from the group consisting of blood or blood components, bronchoalveolar lavage, cerebrospinal fluid, nasal swabs, sputum, stool, throat swabs, vaginal swabs, urine, and wound swabs, or a combination thereof.